NCT02191787View on ClinicalTrials.gov

Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

May 31, 1998

Conditions
Healthy
Interventions
DRUG

Seresis®

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02191787 - Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers | Biotech Hunter | Biotech Hunter